Inspections & Audits

The purpose of the Inspections and Audits stop is to perform any inspections or audits that might be required by the Regulatory Authority, IRB, or Trial Sponsor.

DTRA_Tubestop Icons_Red-23

DCT-specific Considerations/Inputs

Per FDA Draft Guidance, the FDA will expect to have an identified location to review data collected by a Principal investigator. When a virtual PI is involved, a physical location for audit will still need to be identified. 


Description


Tools


Tools

Bring Your Own Technology (BYOT)


Regulatory Documents

FDA/U.S.

U.S. FDA Final Guidance Document: Conducting Clinical Trials With Decentralized Elements Guidance for Industry, Investigators, and Other Interested Parties - September 2024

View

Europe/EMA

EMA Recommendation on Decentralized Elements in Clinical Trials

View

Reference Documents

TransCelerate Modernizing Clinical Trial Conduct Solutions

View